Mohamed Labedi

475 total citations
24 papers, 317 citations indexed

About

Mohamed Labedi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Mohamed Labedi has authored 24 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Mohamed Labedi's work include Atrial Fibrillation Management and Outcomes (10 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (6 papers). Mohamed Labedi is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Cardiac Arrhythmias and Treatments (9 papers) and Cardiac pacing and defibrillation studies (6 papers). Mohamed Labedi collaborates with scholars based in United States. Mohamed Labedi's co-authors include Josef Stehlik, B.B. Reid, Omar Wever‐Pinzon, Erin Davis, Edward M. Gilbert, Stavros G. Drakos, Abdallah G. Kfoury, Dean Y. Li, Abdulfattah Saidi and Gregory J. Stoddard and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Mohamed Labedi

23 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Labedi United States 8 181 173 170 71 55 24 317
A. Lafont France 7 135 0.7× 131 0.8× 156 0.9× 91 1.3× 23 0.4× 13 282
Cosimo D’Alessandro France 8 116 0.6× 175 1.0× 260 1.5× 44 0.6× 88 1.6× 16 348
Harveen K. Lamba United States 7 128 0.7× 151 0.9× 201 1.2× 47 0.7× 43 0.8× 42 291
Philipp Angleitner Austria 12 129 0.7× 207 1.2× 264 1.6× 97 1.4× 21 0.4× 43 359
Christiaan F J Antonides Netherlands 7 127 0.7× 288 1.7× 279 1.6× 122 1.7× 36 0.7× 13 349
Karol Mudy United States 6 60 0.3× 67 0.4× 105 0.6× 19 0.3× 36 0.7× 15 169
Graham Peigh United States 11 185 1.0× 68 0.4× 61 0.4× 55 0.8× 20 0.4× 35 286
Jessica Weimann Germany 8 132 0.7× 92 0.5× 102 0.6× 83 1.2× 36 0.7× 29 224
C. Gidea United States 9 88 0.5× 67 0.4× 199 1.2× 14 0.2× 15 0.3× 39 304
Jessica Bresson United States 9 89 0.5× 176 1.0× 311 1.8× 28 0.4× 38 0.7× 10 370

Countries citing papers authored by Mohamed Labedi

Since Specialization
Citations

This map shows the geographic impact of Mohamed Labedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Labedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Labedi more than expected).

Fields of papers citing papers by Mohamed Labedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Labedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Labedi. The network helps show where Mohamed Labedi may publish in the future.

Co-authorship network of co-authors of Mohamed Labedi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Labedi. A scholar is included among the top collaborators of Mohamed Labedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Labedi. Mohamed Labedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Harsh, Aakash Sheth, Bhavin Patel, et al.. (2025). Long‐Term Impact of GLP‐1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients. Journal of Cardiovascular Electrophysiology. 36(8). 1808–1816. 3 indexed citations
2.
Sheth, Aakash, Harsh Patel, Gurukripa N. Kowlgi, et al.. (2024). CE-482907-002 IMPACT OF GLP-1 AGONISTS IN PATIENTS WITH ATRIAL FIBRILLATION ABLATION. Heart Rhythm. 21(5). S41–S42. 2 indexed citations
3.
Patel, Harsh, Aakash Sheth, Bhavin Patel, et al.. (2024). MP-483497-005 IMPACT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION. Heart Rhythm. 21(5). S101–S102. 1 indexed citations
4.
Ullah, Waqas, et al.. (2024). Cardiac Amyloidosis Versus Other Restrictive Cardiomyopathies: A Retrospective Analysis of Cardiovascular Outcomes and Arrhythmic Burden. Clinical Medicine Insights Cardiology. 18. 1987801590–1987801590. 1 indexed citations
5.
Agarwal, Siddharth, Harsh Patel, Justin Z. Lee, et al.. (2023). Impact of Frailty on Outcomes of Patients Who Underwent Catheter Ablation for Ventricular Tachycardia. The American Journal of Cardiology. 206. 49–52. 1 indexed citations
6.
Al‐Khadra, Yasser, et al.. (2022). Outcomes of catheter ablation versus antiarrhythmic therapy in patients with atrial fibrillation: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 65(3). 773–802. 9 indexed citations
7.
Labedi, Mohamed, et al.. (2022). Atrial fibrillation: Rate control or rhythm control?. Cleveland Clinic Journal of Medicine. 89(10). 567–571. 2 indexed citations
8.
Bhattarai, Mukul, et al.. (2022). Prediction of Recurrence of Atrial Fibrillation Post-ablation Based onAtrial Fibrosis Seen on Late Gadolinium Enhancement MRI: A Metaanalysis. Current Cardiology Reviews. 19(3). e051222211571–e051222211571. 3 indexed citations
9.
10.
Labedi, Mohamed, et al.. (2021). PAPILLARY FIBROELASTOMA OF PULMONARY VALVE - A RARE CAUSE OF HEMOPTYSIS. Journal of the American College of Cardiology. 77(18). 2885–2885. 1 indexed citations
11.
Ibrahim, Abdisamad, et al.. (2020). The Ubiquitous Premature Ventricular Complex. Cureus. 12(1). e6585–e6585. 9 indexed citations
12.
13.
Salih, Mohsin, Yousef Darrat, Abdisamad Ibrahim, et al.. (2020). Clinical outcomes of adjunctive posterior wall isolation in persistent atrial fibrillation: A meta‐analysis. Journal of Cardiovascular Electrophysiology. 31(6). 1394–1402. 32 indexed citations
14.
Ibrahim, Abdisamad, et al.. (2019). Meta-Analysis Evaluating Outcomes of Surgical Left Atrial Appendage Occlusion During Cardiac Surgery. The American Journal of Cardiology. 124(8). 1218–1225. 14 indexed citations
15.
Labedi, Mohamed & Nassir F. Marrouche. (2016). Invasive treatment of atrial fibrillation. Current Opinion in Cardiology. 31(4). 366–373. 1 indexed citations
16.
White, Robert B., Mohamed Labedi, Jordan B. King, et al.. (2016). Atrial fibrosis progression in patients with Atrial Fibrillation. Journal of Cardiovascular Magnetic Resonance. 18. P149–P149. 1 indexed citations
17.
Wever‐Pinzon, Omar, Craig H. Selzman, Stavros G. Drakos, et al.. (2013). Pulsatility and the Risk of Nonsurgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II. Circulation Heart Failure. 6(3). 517–526. 150 indexed citations
18.
Labedi, Mohamed, et al.. (2013). Electromagnetic Interference of Automatic Implantable Cardioverter Defibrillator and HeartWare Left Ventricular Assist Device. ASAIO Journal. 59(2). 136–139. 19 indexed citations
19.
Stehlik, Josef, Mohamed Labedi, Dylan V. Miller, & Mónica P. Revelo. (2012). Abnormal Finding on a Screening Endomyocardial Biopsy. American Journal of Transplantation. 12(2). 499–501. 1 indexed citations
20.
Labedi, Mohamed, Abdallah G. Kfoury, Josef Stehlik, et al.. (2012). 235 Thrombus within the HeartMate II Left Ventricular Assist Device (LVAD): Are All Clots Created Equal?. The Journal of Heart and Lung Transplantation. 31(4). S85–S86. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Lafont Breakdown of academic impact, for papers by Cosimo D’Alessandro Breakdown of academic impact, for papers by Harveen K. Lamba Breakdown of academic impact, for papers by Philipp Angleitner Breakdown of academic impact, for papers by Christiaan F J Antonides Breakdown of academic impact, for papers by Karol Mudy Breakdown of academic impact, for papers by Graham Peigh Breakdown of academic impact, for papers by Jessica Weimann Breakdown of academic impact, for papers by C. Gidea Breakdown of academic impact, for papers by Jessica Bresson
Rankless by CCL
2026